Company / Book Value per Share
Serina Therapeutics, Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.004
FY2025
5-year range
-$29.93 / $0.266
FY2021-FY2025
Trend
-101.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$29.93 to -$0.004 over the past 2 years.
Based on SEC 10-K filings.
-$0.004 in FY2025.
Improved from -$29.93 to -$0.004 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, book value per share decreased 101.7% year-over-year.
- Peak book value per share was recorded in FY2024.
- Lowest book value per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.004 | -101.7% |
| FY2024 | $0.266 | +100.9% |
| FY2023 | -$29.93 | -6497.5% |
| FY2022 | -$0.454 | -44.5% |
| FY2021 | -$0.314 | -131.0% |
| FY2020 | -$0.136 | -161.6% |
| FY2018 | $0.221 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026